Medtech startup AliveCor announced this morning it has pulled in $30 million from Omron Healthcare and the Mayo Clinic and is launching an artificially intelligent stroke prevention platform for doctors called KardiaPro. AliveCor already has an FDA-cleared mobile app called Kardia to accompany its $99 standalone EKG reader device. However, a partnership last year with the Mayo Clinic involving 4,500 patients for a major study on stroke prompted the company to build the new platform, which is a premium offering for doctors who want to monitor the EKG readouts of patients at potential risk for stroke or other heart-related diseases. KardiaPro will track a number of factors for at-risk patients, including weight, activity and blood pressure and then runs them through the AliveCor AI technology to suss out potential triggers doctors may not detect on their own. The platform then feeds what AliveCor CEO Vic Gundotra refers to as a "personal heart profile" for patients that can then be used to send alerts to the doctor to help them determine the next course of action. AliveCor raised $13.5 million previously from Khosla Ventures, Qualcomm and Burrill and Company.